keyword
https://read.qxmd.com/read/38649870/necrotising-fasciitis-with-extensive-necrosis-caused-by-lactobacillus-a-case-report
#1
JOURNAL ARTICLE
Jun Nagayama, Takeo Sato, Ishida Takanori, Koga Kouji, Nakamura Mitsunobu
BACKGROUND: Necrotising fasciitis (NF) is a life-threatening soft-tissue infection that rapidly destroys the epidermis, subcutaneous tissue, and fascia. Despite their low virulence, Lactobacillus spp. can cause NF, and because of its rare incidence, there is limited information about its molecular and clinicopathological characteristics. We report a rare case of NF in a patient with type 2 diabetes mellitus diagnosed on admission and severe obesity due to infection with two types of Lactobacillus spp...
April 22, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38642101/a-rat-model-of-operant-negative-reinforcement-in-opioid-dependent-males-and-females
#2
JOURNAL ARTICLE
Jonathan J Chow, Kayla M Pitts, Jules M Chabot, Rutsuko Ito, Yavin Shaham
RATIONALE AND OBJECTIVE: Avoidance of opioid withdrawal plays a key role in human opioid addiction. Here, we present a procedure for studying operant negative reinforcement in rats that was inspired by primate procedures where opioid-dependent subjects lever-press to prevent naloxone infusions. METHODS: In Experiment 1, we trained rats (n = 30, 15 females) to lever-press to escape and then avoid mild footshocks (0.13-0.27 mA) for 35 days (30 trials/d)...
April 20, 2024: Psychopharmacology
https://read.qxmd.com/read/38627684/haic-combined-with-lenvatinib-plus-pd-1-versus-lenvatinib-plus-pd-1-in-patients-with-high-risk-advanced-hcc-a-real-world-study
#3
JOURNAL ARTICLE
Xu Chang, Xinge Li, Peng Sun, Zhenfeng Li, Pengfei Sun, Shangkun Ning
BACKGROUND: The treatment of hepatocellular carcinoma (HCC) patients exhibiting high-risk characteristics (Vp4, and/or bile duct invasion, and/or tumor occupancy ≥ 50%) lacks standardized approaches and yields unfavorable results. This study endeavors to evaluate the safety, efficacy, and prognostic impacts of employing hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and humanized programmed death receptor-1 (PD-1) in the treatment of high-risk HCC patients...
April 16, 2024: BMC Cancer
https://read.qxmd.com/read/38611287/-bacillus-subtilis-edible-films-for-strawberry-preservation-antifungal-efficacy-and-quality-at-varied-temperatures
#4
JOURNAL ARTICLE
Jesús Rubén Torres-García, Arnulfo Leonardo-Elias, María Valentina Angoa-Pérez, Edgar Villar-Luna, Sergio Arias-Martínez, Guadalupe Oyoque-Salcedo, Ernesto Oregel-Zamudio
Fungal infestations, particularly from Rhizopus stolonifer , pose significant post-harvest challenges for strawberries, compromising their shelf life and quality. Traditional preservation methods, including refrigeration, offer limited protection against such pathogens. This study introduces an innovative approach, utilizing edible films infused with Bacillus subtilis strains GOS 01 B-67748 and HFC 103, known for their antifungal properties. We demonstrate that these bioactive films not only inhibit fungal growth effectively but also enhance the preservation of strawberries at varying temperatures...
March 22, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38609152/proceedings-of-the-2023-viral-clearance-symposium-2023-vcs-summary-pending-questions-and-next-steps
#5
JOURNAL ARTICLE
David Roush, Glen Bolton
The 2023 Viral Clearance Symposium (VCS) was hosted by Takeda on 24 and 25 May 2023 in Vienna, Austria. The present conference extended the structure of the previous biennial symposia held between 2009 and 2019. As recapitulated in the introductory session, the genesis of the VCS, as described in the Proceedings of the 2009 VCS was "the worldwide regulatory and industry recognition that challenges, gaps, and opportunities exist, that it formally addressed could benefit the field as whole." This report provides a synopsis of the progress achieved at the conference resulting from detailed technical discussions and the pending questions that still require attention to address...
2024: PDA Journal of Pharmaceutical Science and Technology
https://read.qxmd.com/read/38592343/six-year-real-world-use-of-prophylaxis-with-recombinant-factor-ix-albumin-fusion-protein-rix-fp-in-persons-with-hemophilia-b-a-single-center-retrospective-prospective-study
#6
JOURNAL ARTICLE
Antonio Coppola, Gianna Franca Rivolta, Gabriele Quintavalle, Annalisa Matichecchia, Federica Riccardi, Rossana Rossi, Anna Benegiamo, Paola Ranalli, Valeria Coluccio, Annarita Tagliaferri
Background : Extended half-life (EHL) factor IX (FIX) concentrates allow for prophylaxis with prolonged dosing intervals and high bleeding protection in persons with hemophilia B. Long-term real-world studies are lacking. Methods : In a retrospective-prospective study, the six-year use of prophylaxis with the EHL recombinant FIX-albumin fusion protein (rIX-FP) was analyzed, comparing outcomes with previous standard half-life (SHL) FIX in patients already on prophylaxis. Results : Prophylaxis with rIX-FP was prescribed in 15 patients (10 severe, 5 moderate; follow-up: 57 ± 17 months)...
March 6, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38569153/dexmedetomidine-for-preventing-sleep-disturbance-after-ambulatory-anesthesia-a-case-report
#7
JOURNAL ARTICLE
Jacqueline Quinn, James C Krakowski
Propofol anesthesia may impact a patient's sleep quality in the immediate postprocedure timeframe. We describe a 24-year-old man presenting for gastrostomy-jejunostomy tube replacement who reported debilitating sleep-onset disturbances after 3 previous anesthetic exposures for the same procedure. Review of the patient's records revealed the recurring use of propofol infusion. We proposed using dexmedetomidine infusion to potentially avoid another extended sleep disturbance. Following a dexmedetomidine-centered plan, the patient reported experiencing his usual sleep pattern without side-effects for 5 consecutive days postprocedure...
April 1, 2024: A&A Practice
https://read.qxmd.com/read/38552877/in-vitro-activity-pharmacodynamic-profile-and-dose-optimization-of-biapenem-against-ndm-and-oxa-48-like-carbapenemase-producing-klebsiella-pneumoniae-a-multicenter-study-in-thailand
#8
JOURNAL ARTICLE
Worapong Nasomsong, Chirakhana Siangtrong, Parnrada Nulsopapon, Supanun Pungcharoenkijkul, Patcharapa Boonmee, Wichai Santimaleeworagun
BACKGROUND: Biapenem (BIPM) exhibited a less efficient substrate for various Metallo-β-lactamase (MBL) than other carbapenems. OBJECTIVE: We aimed to evaluate in vitro susceptibility data of BIPM, and optimal dose based on Monte Carlo simulation to extend treatment options. METHODS: We collected 192 carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates from unique patients among multicenters in Thailand, from June 2019-March 2023...
March 27, 2024: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/38549492/riding-the-wave-of-change-providing-solid-ground-to-support-nursing-with-patient-transitions-to-novel-haemophilia-therapies
#9
JOURNAL ARTICLE
Erica Crilly, Cathy Harrison, Jennifer Maahs, Marlene Beijlevelt, Brian Ramsay, Cyrus Githinji, Marcela Sisdelli, Anjalin Dsouza
INTRODUCTION: Haemophilia nursing practice has experienced a shift in the past decade, as the historic chief focus on factor infusions shifted to extended half-life products, bispecific antibody therapies and other non-replacement therapies. This evolution has driven a need for changes in nursing practice in many haemophilia treatment centres. AIM: This article intends to provide insights to the haemophilia nurse to champion practice changes at their haemophilia treatment centres...
March 29, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38549463/classification-of-recombinant-factor-viii-products-and-implications-for-clinical-practice-a-systematic-literature-review
#10
REVIEW
Cihan Ay, Mariasanta Napolitano, Abel Hassoun, Radovan Tomic, Cedric Martin, Wilfried Seifert, Karen Pinachyan, Johannes Oldenburg
INTRODUCTION: Consensus over the definition of recombinant factor VIII (rFVIII) product classification in haemophilia A is lacking. rFVIII products are often classified as standard half-life (SHL) or extended half-life (EHL); despite this, no universally accepted definition currently exists. One proposed definition includes half-life, area under the curve, and technology designed to extend half-life; however, the International Society on Thrombosis and Haemostasis defines activity over time as the most intuitive information for building treatment regimens and the World Federation of Hemophilia describes rFVIII product classification in terms of infusion frequency...
March 29, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38549220/patients-with-hepatocellular-carcinoma-extrahepatic-metastases-can-benefit-from-hepatic-arterial-infusion-chemotherapy-combined-with-lenvatinib-plus-programmed-death-1-inhibitors
#11
JOURNAL ARTICLE
Renguo Guan, Nan Zhang, Min Deng, Ye Lin, Guanjie Huang, Yizhen Fu, Zehao Zheng, Wei Wei, Chong Zhong, Haitao Zhao, Jie Mei, Rongping Guo
BACKGROUND: Lenvatinib plus Programmed Death-1 (PD-1) inhibitors (LEN-P) have been recommended in China for patients with advanced hepatocellular carcinoma (HCC). However, they provide limited survival benefits to patients with extrahepatic metastases. We aimed to investigate whether combining hepatic arterial infusion chemotherapy (HAIC) with LEN-P could improve its efficacy. MATERIALS AND METHODS: This multi-center cohort study included patients with HCC extrahepatic metastases who received HAIC combined with LEN-P (HAIC-LEN-P group, n=127) or LEN-P alone (n=103) as the primary systemic treatment between January 2019 and December 2022...
March 28, 2024: International Journal of Surgery
https://read.qxmd.com/read/38536810/caregivers-of-children-with-hiv-in-botswana-prefer-monthly-iv-broadly-neutralizing-antibodies-bnabs-to-daily-oral-art
#12
JOURNAL ARTICLE
Maureen Sakoi-Mosetlhi, Gbolahan Ajibola, Roxanna Haghighat, Oganne Batlang, Kenneth Maswabi, Molly Pretorius-Holme, Kathleen M Powis, Shahin Lockman, Joseph Makhema, Mathias Litcherfeld, Daniel R Kuritzkes, Roger Shapiro
INTRODUCTION: Monthly intravenous infusion of broadly neutralizing monoclonal antibodies may be an attractive alternative to daily oral antiretroviral treatment for children living with HIV. However, acceptability among caregivers remains unknown. METHODS: We evaluated monthly infusion of dual bNAbs (VRCO1LS and 10-1074) as a treatment alternative to ART among children participating in the Tatelo Study in Botswana. Eligible children aged 2-5 years received 8-32 weeks of bNAbs overlapping with ART, and up to 24 weeks of bNAbs alone as monthly intravenous infusion...
2024: PloS One
https://read.qxmd.com/read/38528196/nonocclusive-mesenteric-ischemia-nomi-on-roux-limb-after-biliary-reconstruction-successfully-treated-by-interventional-radiology-ivr
#13
JOURNAL ARTICLE
Makoto Kawamoto, Yoshihiro Miyasaka, Nobuhiko Koreeda, Yousuke Hirano, Ryotaro Yamamoto, Masato Watanabe
Nonocclusive mesenteric ischemia (NOMI) is a life-threatening disorder. Early diagnosis is challenging because NOMI lacks specific symptoms. A 52-year-old man who received extended cholecystectomy with Roux-en-Y hepaticojejunostomy for gallbladder cancer (GBC) presented to our hospital with nausea and vomiting. Neither tender nor peritoneal irritation sign was present on abdominal examination. Blood test exhibited marked leukocytosis (WBC:19,800/mm3). A contrast-enhanced abdominal computed tomography (CT) scan revealed remarkable wall thickening and lower contrast enhancement effect localized to Roux limb...
March 25, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38528126/the-origin-and-course-of-the-blood-supply-to-the-lower-eyelid-orbital-fat-anatomical-study-and-clinical-significance
#14
JOURNAL ARTICLE
Fan Yang, Tao Shan, Cong Li, Yu Sun, Ruowu Shen, Chuanping Gao, Zhiguo Wang
PURPOSE: The aim of this study is to investigate the origin and course of the orbital fat arterial supply in the lower eyelid using traditional anatomy and three-dimensional computed tomography (CT). METHODS: Twenty-seven cadaver heads were infused with mercury sulfide contrast media through the ophthalmic artery, maxillary artery, transverse facial artery, and facial artery. CT images were obtained after contrast agent injection, three-dimensional CT scans were reconstructed, and the cadaver heads were dissected...
March 25, 2024: Aesthetic Plastic Surgery
https://read.qxmd.com/read/38526051/updated-antimicrobial-dosing-recommendations-for-obese-patients
#15
REVIEW
Ana Castro-Balado, Iria Varela-Rey, Beatriz Mejuto, Cristina Mondelo-García, Irene Zarra-Ferro, Teresa Rodríguez-Jato, Anxo Fernández-Ferreiro
The prevalence of obesity has increased considerably in the last few decades. Pathophysiological changes in obese patients lead to pharmacokinetic (PK) and pharmacodynamic (PD) alterations that can condition the correct exposure to antimicrobials if standard dosages are used. Inadequate dosing in obese patients can lead to toxicity or therapeutic failure. In recent years, additional antimicrobial PK/PD data, extended infusion strategies, and studies in critically ill patients have made it possible to obtain data to provide a better dosage in obese patients...
March 25, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38520664/cost-effectiveness-analysis-of-etranacogene-dezaparvovec-versus-extended-half-life-prophylaxis-for-moderate-to-severe-haemophilia-b-in-germany
#16
REVIEW
Niklaus Meier, Hendrik Fuchs, Katya Galactionova, Cedric Hermans, Mark Pletscher, Matthias Schwenkglenks
BACKGROUND AND OBJECTIVE: Haemophilia B is a rare genetic disease that is caused by a deficiency of coagulation factor IX (FIX) in the blood and leads to internal and external bleeding. Under the current standard of care, haemophilia is treated either prophylactically or on-demand via intravenous infusions of FIX. These treatment strategies impose a high burden on patients and health care systems as haemophilia B requires lifelong treatment, and FIX is costly. Etranacogene dezaparvovec (ED) is a gene therapy for haemophilia B that has been recently approved by the United States Food and Drug Administration and has received a recommendation for conditional marketing authorization by the European Medicines Agency...
March 23, 2024: PharmacoEconomics Open
https://read.qxmd.com/read/38508545/sodium-alginate-films-incorporated-with-lepidium-sativum-garden-cress-extract-as-a-novel-method-to-enhancement-the-oxidative-stability-of-edible-oil
#17
JOURNAL ARTICLE
Azizah A Alshehri, Reham M Kamel, Heba Gamal, Hazem Sakr, Mohamed Saleh, Mohamed El-Bana, El-Shahat Gomaa El-Dreny, Enas El-Fadly, Mohamed Abdin, Mohamed Abdelbaset Salama, Mahmoud Elsayed
This study addresses the growing interest in bio-based active food packaging by infusing Lepidium sativum (Garden cress) seeds extract (GRCE) into sodium alginate (SALG) films at varying concentrations (1, 3, and 5 %). The GRCE extract revealed six phenolic compounds, with gallic and chlorogenic acids being prominent, showcasing substantial total phenolic content (TPC) of 139.36 μg GAE/mg and total flavonoid content (TFC) of 26.46 μg RE/mg. The integration into SALG films significantly increased TPC, reaching 30...
March 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38505594/anesthetic-managements-morbidities-and-mortalities-in-retroperitoneal-sarcoma-patients-experiencing-perioperative-massive-blood-transfusion
#18
JOURNAL ARTICLE
Jun Wang, Jun Chen, Kunpeng Liu, Hua Zhang, Yue Wei, Libin Suo, Shuang Lan, Yanzhen Wang, Chenghua Luo, Lan Yao
OBJECTIVE: Given high risks of major bleeding during retroperitoneal sarcoma(RPS) surgeries, severe complications and deaths are common to see perioperatively. Thus, effective anesthetic management is the key point to ensuring the safety of patients. This study aimed to introduce anesthesia management and mortalities in RPS patients receiving massive blood transfusions during surgeries. METHODS: Records of RPS surgeries under general anesthesia from January 2016 through December 2021 were retrospectively retrieved from our database...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38491119/development-of-extended-pharmacokinetic-models-for-propofol-based-on-measured-blood-and-brain-concentrations
#19
JOURNAL ARTICLE
Masayoshi Kawata, Atsushi Yonezawa, Yohei Mineharu, Kotaro Itohara, Toshiyuki Mizota, Yoshihiro Matsui, Takayuki Kikuchi, Yukihiro Yamao, Etsuko Yamamoto Hattori, Miho Hamada, Daiki Hira, Keiko Furukawa, Susumu Miyamoto, Tomohiro Terada, Kazuo Matsubara, Yoshiki Arakawa
Propofol's pharmacokinetics have been extensively studied using human blood samples and applied to target-controlled infusion systems; however, information on its concentration in the brain remains scarce. Therefore, this study aimed to simultaneously measure propofol plasma and brain concentrations in patients who underwent awake craniotomy and establish new pharmacokinetic model. Fifty-seven patients with brain tumors or brain lesions who underwent awake craniotomy were sequentially assigned to model-building and validating groups...
March 15, 2024: Scientific Reports
https://read.qxmd.com/read/38487678/fibrinolysis-biomarker-thrombin-and-activated-protein-c-level-alterations-after-coagulation-activation-depend-on-type-of-thrombophilia-and-clinical-phenotype
#20
JOURNAL ARTICLE
Sara Reda, Nadine Schwarz, Jens Müller, Hannah L McRae, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl
BACKGROUND: Recently, we have shown alterations in the anticoagulant response to recombinant activated factor VII (rFVIIa)-induced coagulation activation in patients with thrombophilia. OBJECTIVES: This study aimed to extend this in vivo model to fibrinolysis biomarkers. METHODS: This interventional in vivo study included 56 patients with thrombophilia and previous venous thromboembolism (VTE+), 38 without VTE (VTE-), and 35 healthy controls...
February 2024: Research and Practice in Thrombosis and Haemostasis
keyword
keyword
49768
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.